Abstract
Inherited disorders of energy metabolism are increasingly being recognized as important causes of cardiomyopathy in children. We previously reported that heteroplasmic point substitutions in the mitochondrial DNA D-loop were found in 15 of 75 children at risk for mitochondrial disease (vs 0/95 controls). Four of these cases presented with severe cardiomyopathy in congestive failure in addition to other anomalies and are presented here. In each case, myocardial dysfunction greatly improved following supportive therapy aimed at reversing both congestive failure and catabolism. D-loop point heteroplasmy may be a marker for severe, reversible, infantile multisystem disease that can present with cardiomyopathy.
Similar content being viewed by others
References
E Arbustini M Diegoli R Fasani et al. (1998) ArticleTitleMitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol 153 1501–1510 Occurrence Handle1:CAS:528:DyaK1cXns1Ogsrw%3D Occurrence Handle9811342
D Bonnet P de Lonlay I Gautier et al. (1988) ArticleTitleEfficiency of metabolic screening in childhood cardiomyopathies. Eur Heart J 19 790–793 Occurrence Handle10.1053/euhj.1997.0818
S DiMauro M Hirano (1998) ArticleTitleMitochondria and heart disease. Curr Opin Cordial 13 190–197 Occurrence Handle1:STN:280:DyaK1czhtlKhug%3D%3D
RA Friedman JP Moak A Garson (1991) ArticleTitleClinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol 18 152–156 Occurrence Handle1:STN:280:By6B28fjvFY%3D Occurrence Handle2050918
M Ito ST Le D Chaudhari et al. (2001) ArticleTitleScreening for mitochondrial DNA heteroplasmy in children at risk for mitochondrial disease. Mitochondrion 1 269–278 Occurrence Handle10.1016/S1567-7249(01)00028-9 Occurrence Handle1:CAS:528:DC%2BD3MXotFKitLg%3D
AB Lewis M Chabot (1991) ArticleTitleOutcome of infants and children with dilated cardiomyopathy. Am J Cardiol 68 365–369 Occurrence Handle1858677
MITOMAP (2001) A human mitochondrial genome database. Center for Molecular Medicine, Emory University, Atlanta, GA, USA. http://www.gen.emory.edu/mitomap.html
JM Saudubray D Martin P de Lonlay et al. (1999) ArticleTitleRecognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 22 488–502
ML Schwartz GF Cox AE Lin et al. (1996) ArticleTitleClinical approach to genetic cardiomyopathy in children. Circulation 94 2021–2038 Occurrence Handle1:STN:280:ByiD38jlsVY%3D Occurrence Handle8873681
JM Shoffner (2001) Oxidative phosphorylation diseases. CR Scriver (Eds) et al. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. McGraw-Hill New York 2367–2423
Acknowledgements
This work was supported in part by a grant from the United Mitochondrial Disease Foundation and a Research Career Development Award from the Childrens Hospital Los Angeles Research Institute. We thank the clinicians who referred patients and provided samples for DNA analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boles, R., Luna, C. & Ito, M. Severe Reversible Cardiomyopathy in Four Unrelated Infants Associated with Mitochondrial DNA D-Loop Heteroplasmy . Pediatr Cardiol 24, 484–487 (2003). https://doi.org/10.1007/s00246-002-0263-8
Published:
Issue date:
DOI: https://doi.org/10.1007/s00246-002-0263-8